Kalbe Farma Financials
| KLBF Stock | IDR 1,505 35.00 2.38% |
Kalbe |
Understanding current and past Kalbe Farma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Kalbe Farma's financial statements are interrelated, with each one affecting the others. For example, an increase in Kalbe Farma's assets may result in an increase in income on the income statement.
| Instrument | Indonesia Stock View All |
| Exchange | Jakarta Exchange |
| ISIN | ID1000125107 |
| Business Address | Gedung KALBE, Jakarta, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.kalbe.co.id |
| Phone | 62 21 4287 3888 |
| Currency | IDR - Indonesian Rupiah |
You should never invest in Kalbe Farma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Kalbe Stock, because this is throwing your money away. Analyzing the key information contained in Kalbe Farma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Kalbe Farma Key Financial Ratios
Kalbe Farma's financial ratios allow both analysts and investors to convert raw data from Kalbe Farma's financial statements into concise, actionable information that can be used to evaluate the performance of Kalbe Farma over time and compare it to other companies across industries.| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Target Price | 2345.0 | |||
| Beta | 0.32 | |||
| Last Dividend Paid | 35.0 |
Kalbe Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kalbe Farma's current stock value. Our valuation model uses many indicators to compare Kalbe Farma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kalbe Farma competition to find correlations between indicators driving Kalbe Farma's intrinsic value. More Info.Kalbe Farma Tbk is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kalbe Farma Tbk is roughly 1.58 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kalbe Farma's earnings, one of the primary drivers of an investment's value.Kalbe Farma Tbk Systematic Risk
Kalbe Farma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kalbe Farma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Kalbe Farma Tbk correlated with the market. If Beta is less than 0 Kalbe Farma generally moves in the opposite direction as compared to the market. If Kalbe Farma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kalbe Farma Tbk is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kalbe Farma is generally in the same direction as the market. If Beta > 1 Kalbe Farma moves generally in the same direction as, but more than the movement of the benchmark.
Kalbe Farma November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kalbe Farma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kalbe Farma Tbk. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kalbe Farma Tbk based on widely used predictive technical indicators. In general, we focus on analyzing Kalbe Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kalbe Farma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 7.58 | |||
| Value At Risk | (2.79) | |||
| Potential Upside | 2.64 |
Other Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.